Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism

Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism

Abstract Dominant defects in CHCHD10, a mitochondrial intermembrane space protein, lead to a range of neurological and muscle disease phenotypes including amyotrophic lateral sclerosis. Many patients present with spinal muscular atrophy Jokela type (SMAJ), which is caused by heterozygous p.G66V vari...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandra Harjuhaahto, Manu Jokela, Jayasimman Rajendran, Minea Rokka, Bowen Hu, Jouni Kvist, Fuping Zhang, Tomáš Zárybnický, Kimmo Haimilahti, Liliya Euro, Eija Pirinen, Nadine Huber, Sanna-Kaisa Herukka, Annakaisa Haapasalo, Emilia Kuuluvainen, Swetha Gopalakrishnan, Pekka Katajisto, Ville Hietakangas, Thibaut Burg, Ludo Van Den Bosch, Xiaoping Huang, Derek P. Narendra, Satu Kuure, Emil Ylikallio, Henna Tyynismaa
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Acta Neuropathologica Communications
Subjects:
CHCHD10
CHCHD2
ALS
Mitochondria
Creatine
Metabolomics
Online Access:https://doi.org/10.1186/s40478-025-02039-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40478-025-02039-3

Similar Items